Cannabinoid CB1 receptor restrains accentuated activity of hypothalamic corticotropin-releasing factor and brainstem tyrosine hydroxylase neurons in endotoxemia-induced hypophagia in rats

被引:8
作者
Rorato, Rodrigo [1 ]
Reis, Wagner Luis [1 ]
Borges, Beatriz de Carvalho [1 ]
Antunes-Rodrigues, Jose [1 ]
Kagohara Elias, Lucila Leico [1 ]
机构
[1] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Physiol, BR-14049900 Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Food intake; LPS; CB1; receptor; CRF; TH; PITUITARY-ADRENAL AXIS; VAGAL AFFERENT NEURONS; PARAVENTRICULAR NUCLEUS; INVERSE AGONISM; HPA AXIS; IN-VIVO; EXPRESSION; ACTIVATION; RESPONSES; CHOLECYSTOKININ;
D O I
10.1016/j.neuropharm.2011.11.009
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It is well known that endocannabinoids play an important role in the regulation of food intake and body weight. Endocannabinoids and cannabinoid receptors are found in the hypothalamus and brainstem, which are central areas involved in the control of food intake and energy expenditure. Activation of these areas is related to hypophagia observed during inflammatory stimulus. This study investigated the effects of cannabinoid (CB1) receptor blockade on lipopolysaccharide (LPS)-induced hypophagia. Male Wistar rats were pretreated with rimonabant (10 mg/kg, by gavage) or vehicle; 30 min later they received an injection of either LPS (100 mu g/kg, intraperitoneal) or saline. Food intake, body weight, corticosterone response, CRF and CART mRNA expression, Fos-CRF and Fos-alpha-MSH immunoreactivity in the hypothalamus and Fos-tyrosine hydroxylase (TH) immunoreactivity in the brainstem were evaluated. LPS administration decreased food intake and body weight gain and increased plasma corticosterone levels and CRF mRNA expression in the PVN. We also observed an increase in Fos-CRF and Fos-TH double-labeled neurons after LPS injection in vehicle-pretreated rats, with no changes in CART mRNA or Fos-alpha-MSH immunoreactive neurons in the ARC. In saline-treated animals, rimonabant pretreatment decreased food intake and body weight gain but did not modify hormone response or Fos expression in the hypothalamus and brainstem compared with vehicle-pretreated rats. Rimonabant pretreatment potentiated LPS-induced hypophagia, body weight loss and Fos-CRF and Fos-TH expressing neurons. Rimonabant did not modify corticosterone, CRF mRNA or Fos-alpha-MSH responses in rats treated with LPS. These data suggest that the endocannabinoid system, mediated by CB1 receptors, modulates hypothalamic and brainstem circuitry underlying the hypophagic effect during endotoxemia to prevent an exaggerated food intake decrease. This article is part of a Special Issue entitled 'Central Control of Food Intake'. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:154 / 160
页数:7
相关论文
共 60 条
[1]   Regulation of the Hypothalamic-Pituitary-Adrenal Axis Circadian Rhythm by Endocannabinoids Is Sexually Diergic [J].
Atkinson, Helen C. ;
Leggett, James D. ;
Wood, Susan A. ;
Castrique, Emma S. ;
Kershaw, Yvonne M. ;
Lightman, Stafford L. .
ENDOCRINOLOGY, 2010, 151 (08) :3720-3727
[2]   The role of endogenous cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in vivo and in vitro studies in CB1 receptor knockout mice [J].
Barna, I ;
Zelena, D ;
Arszovszki, AC ;
Ledent, C .
LIFE SCIENCES, 2004, 75 (24) :2959-2970
[3]   Expression of hypothalamic neuropeptides and the desensitization of pituitary-adrenal axis and hypophagia in the endotoxin tolerance [J].
Borges, B. C. ;
Antunes-Rodrigues, J. ;
Castro, M. ;
Bittencourt, J. C. ;
Elias, C. F. ;
Elias, L. L. K. .
HORMONES AND BEHAVIOR, 2007, 52 (04) :508-519
[4]   Leptin resistance and desensitization of hypophagia during prolonged inflammatory challenge [J].
Borges, Beatriz C. ;
Rorato, Rodrigo ;
Avraham, Yosefa ;
da Silva, Lilian E. C. M. ;
Castro, Margaret ;
Vorobiav, Lia ;
Berry, Elliot ;
Antunes-Rodrigues, Jose ;
Elias, Lucila L. K. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2011, 300 (05) :E858-E869
[5]   A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1 - Evidence for a new model of receptor/ligand interactions [J].
Bouaboula, M ;
Perrachon, S ;
Milligan, L ;
Canat, X ;
RinaldiCarmona, M ;
Portier, M ;
Barth, F ;
Calandra, B ;
Pecceu, F ;
Lupker, J ;
Maffrand, JP ;
LeFur, G ;
Casellas, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22330-22339
[6]   Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin [J].
Burdyga, G ;
Lal, S ;
Varro, A ;
Dimaline, R ;
Thompson, DG ;
Dockray, GJ .
JOURNAL OF NEUROSCIENCE, 2004, 24 (11) :2708-2715
[7]   Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype [J].
Burdyga, Galina ;
Varro, Andrea ;
Dimaline, Rod ;
Thompson, David G. ;
Dockray, Graham J. .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2010, 299 (01) :G63-G69
[8]  
CHULUYAN HE, 1992, NEUROENDOCRINOLOGY, V56, P106
[9]   Appetite suppression and weight loss after the cannabinoid antagonist SR141716 [J].
Colombo, G ;
Agabio, R ;
Diaz, G ;
Lobina, C ;
Reali, R ;
Gessa, GL .
LIFE SCIENCES, 1998, 63 (08) :PL113-PL117
[10]  
Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725